Concepedia

Mitchell A. Psotka

MA

33

Publications

2.9K

Citations

23

H-Index

2004

Active since

Affiliations

Alaska Heart and Vascular Institute(Current)

University of California, San Francisco

San Francisco VA Medical Center

University of Missouri–Kansas City

Vanderbilt University Medical Center

Mitchell A. Psotka is an author at Alaska Heart and Vascular Institute specializing in medicine, heart failure, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2004–2024

33

Publications

33

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink et al. · Nature Medicine · 2022 · 814 citations · Full text

Standardized Team-Based Care for Cardiogenic Shock

Behnam Tehrani, Alexander G. Truesdell, Matthew W. Sherwood et al. · Journal of the American College of Cardiology · 2019 · 476 citations · Full text

Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial

Jan Biegus, Adriaan A. Voors, Sean P. Collins et al. · European Heart Journal · 2022 · 196 citations · Full text

A Murine Model of HUS

Tiffany R. Keepers, Mitchell A. Psotka, Lisa K. Gross et al. · Journal of the American Society of Nephrology · 2006 · 145 citations · Full text

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial

Mikhail Kosiborod, Christiane E. Angermann, Sean P. Collins et al. · Circulation · 2022 · 138 citations · Full text

Rows per page

1–5 of 33